| Literature DB >> 25889513 |
Peng Yin1,2, Lihai Zhang3, Tongtong Li4,5, Licheng Zhang6, Guoqi Wang7, Jiantao Li8, Jianheng Liu9, Jianfeng Zhou10, Qun Zhang11, Peifu Tang12.
Abstract
OBJECTIVE: The objective of this study was to evaluate the effectiveness of the treatment of infected nonunion of tibia and femur by bone transport.Entities:
Mesh:
Year: 2015 PMID: 25889513 PMCID: PMC4415215 DOI: 10.1186/s13018-015-0189-5
Source DB: PubMed Journal: J Orthop Surg Res ISSN: 1749-799X Impact factor: 2.359
Proportion of bacterial species growth in culture
|
|
|
|---|---|
|
| 51% |
|
| 18% |
|
| 12% |
|
| 7% |
|
| 5% |
|
| 2% |
|
| 2% |
|
| 1% |
|
| 1% |
|
| 1% |
Figure 1A 19-year-old man who had infected tibia nonunion. (A) This is a 19-year-old man who had infected tibia nonunion with soft tissue defected and foot drop. (B) It shows the picture in operation. (C) Debridement of the site of infected nonunion with 4-cm bone defects and corticotomy of tibia. (D) Two weeks after operation with bone transport. (E) Four weeks after operation with bone transport. (F) Six weeks after operation, bone ends contacted with each other at the docking site and the regenerated bone had begun to be mineralized. (G) Three months after operation, foot drop was corrected and the frame of foot was removed. (H) Five months after operation, good consolidation of the regenerate and complete bone union at the docking site was presented. (I) Seven months after operation, it shows complete bone union, and the apparatus was removed.
Figure 2A 33-year-old man who had an infected femur nonunion. (A) Radiograph of a 33-year-old man who had an infected femur nonunion. (B) Debridement of the site of infected nonunion with 8-cm bone defects and corticotomy of femur. (C) Two months after operation with bone transport. (D) Twelve months after operation, good consolidation of the regenerate and complete bone union at the docking site was presented. (E) The external fixator was removed at 12 months after operation.
Evaluation of the bone results
|
|
|
|
|
|
|---|---|---|---|---|
| Excellent | 46 | 22 | 68 | Union, no infection, deformity <7°, limb length discrepancy (LLD) <2.5 cm |
| Good | 17 | 11 | 28 | Union plus any two of the following: absence of infection, deformity <7°, LLD <2.5 cm. |
| Fair | 7 | 5 | 12 | Union plus any one of the following: absence of infection, deformity <7°, LLD <2.5 cm. |
| Poor | 2 | 0 | 2 | Nonunion/refracture/union plus infection plus deformity >7° plus LLD >2.5 cm |
Evaluation of the functional results
|
|
|
|
|
|
|---|---|---|---|---|
| Excellent | 25 | 12 | 37 | Active, no limp, minimum stiffness (loss of <15° knee extension/<15° ankle dorsiflexion), no reflex sympathetic dystrophy (RSD), insignificant pain. |
| Good | 27 | 15 | 42 | Active, with one or two of the following: limb, stiffness, RSD, significant pain |
| Fair | 13 | 8 | 21 | Active, with three or all of the following: limb, stiffness, RSD, significant pain |
| Poor | 0 | 0 | 0 | Inactive (unemployment or inability to return to daily activities because of injury) |
| Failure | 0 | 0 | 0 | Amputation |
The treatment of infected nonunion of tibia and femur by Ilizarov methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feng | RD, AT, BT (IEF) | 21 | 34.6 | 6.6 | Tibia | 21/21(100%) | 19/2/0/0(Paley) | __ | 0.4(8/12) | 9.8 | 1.48 |
| Arora | RD, AT, BT (MEF) | 15 | 29 | 7.9 | Femur | 15/15(100%) | 12/3/0/0(Arora) | 5/8/2/0(Arora) | 1.33(20/15) | 7.3 | 0.93 |
| Liu | RD, AT, BT (MEF), 5 F | 35 | 37.3 | 3.5 | Tibia | 35/35(100%) | 28/5/2/0(Paley) | 30/4/1/0(Paley) | 1.11(39/35) | 10.7 | 1.36 |
| Sala | RD, AT, BT (IEF/TSF) | 12 | 44 | 8 | Tibia | 12/12(100%) | 10/2/0/0(ASAMI) | 6/5/1/0(ASAMI) | 2.08(25/12) | 13.9 | 2.0 |
| Blum | RD, AT, BT (IEF) | 50 | 29.9 | 8.8 | Femur | 49/50(98%) | __ | __ | __ | 24.5 | 2.8 |
| Megas | RD, AT, CO, or ACL (IEF) | 9 | 39.7 | 5 | Tibia | 9/9(100%) | 5/4/0/0(Paley) | 3/4/2/0(Paley) | 1.44(13/9) | 7.83 | 1.07 |
| Bumbasirevic | RD, AT, BT (IEF) | 30 | 30.4 | 6.9 | Tibia | 29/30(97%) | 19/10/0/1(Paley) | 13/14/2/1(Paley) | 1.4(42/30) | 9.7 | 1.48 |
| Emara | RD, AT, BT (IEF), BG RD, AT, BT (IEF and IMN), BG | 33 | 29 | 6 | Tibia | 16/16(100%) | 15/1/0/0(ASAMI) | 12/1/3/0(ASAMI) | 0.4(6/16) | 8.5 3.1 | 1.5 |
| Tibia | 17/17(100%) | 17/0/0/0(ASAMI) | 13/2/2/0(ASAMI) | 0.12(2/17) | 0.55 | ||||||
| Madhusudhan | RD, AT, ACL (IEF) RD, AT, BT (IEF) | 22 | 37.2 | 4/5.4a | Tibia | 13/13(100%) | 4/3/4/2(ASAMI) | 1/3/6/2(ASAMI)* | 2.73 (60/22) | 9.3 8.5 | 2.33 |
| Tibia | 9/9(100%) | 0/3/4/2(ASAMI) | 0/1/3/2(ASAMI)** | 1.57 | |||||||
| Magadum | RD, ACL (IEF) | 27 | 39 | 10 | Tibia | 24/25(96%)*** | 19/5/0/1(ASAMI) | 15/8/1/1(ASAMI) | 1.16(29/25) | 10.2 | 1.02 |
| Krishnan | RD, AT, BT, or ACL (IEF) | 20 | 38.4 | 6 | Femur | 19/20(95%) | 13/4/1/1(ASAMI) One amputation | 3/9/3/4(ASAMI) One amputation | 3.55(71/20) | 7.8 | 1.28 |
| Sadiris | RD, AT, ACL, or BT (IEF) | 13 | 34.6 | 8.3 | Femur | 13/13(100%) | 8/4/1/0(Paley) | 3/4/4/2(Paley) | 0.76(10/13) | 10.33 | 1.24 |
| Abdel-Aal | RD, BT (IEF) | 9 | 30.66 | 10.7 | Tibia | 9/9(100%) | __ | __ | 1.22(11/9) | 12.78 | 1.22 |
| MaHale | RD, AT, BT, or ACL or CO (IEF) | 10 | 31 | __ | Tibia | 10/10(100%) | __ | __ | __ | 9.0 | __ |
| Arora | RD, BT, or CO (IEF) | 46 | 35 | 6 | Tibia/Femur | 44/46(95.4%) | __ | 15/16/13/2(Paley) | 0.74(34/46) | 8.7 | 1.33 |
| Atesalp | RD, AT, BT (IEF), 3 F | 14 | 25 | 4.4 | Tibia | 13/14(92.9%) | __ | __ | 1.21(17/14) | 6.8 | 1.55 |
| Barbarossa | RD, AT, BT (IEF) | 23 | 40.7 | 6.2 | Tibia | 20/23(87%) | 8/8/2/4(ASAMI) One amputation | 2/10/6/4(ASAMI) One amputation | 3.35(77/23) | __ | __ |
| Maini | RD, AT, BT (IEF) | 15 | 27.4 | 7 | Tibia/Femur | 15/15(100%) | 7/3/0/5(ASAMI) | 4/7/1/3(ASAMI) | 2.06(31/15) | __ | __ |
| Laursen | RD, AT, BT, or CO (IEF) | 9 | 25.78 | 4.89 | Tibia | 9/9(100%) | __ | __ | 1.56(14/9) | 6.7 | __ |
| Ring | RD, BT, or ACL or CO (IEF),3 F | 10 | 34 | 4.3 | Tibia | 9/10(90%) | __ | __ | 1.8(18/10) | 6.9 | __ |
| Hosny | RD, BT, or CO (IEF), 3AT | 11 | 27 | 3.7 | Tibia | 11/11(100%) | __ | 5/3/2/1(Cattaneo) | 1.27(14/11) | 8.5 | 2.3 |
| Dendrinos | RD, BT (IEF) | 28 | 37 | 6 | Tibia | 25/28(89%) | 14/8/1/5(ASAMI) | 7/11/4/5(ASAMI) One amputation | 2.5(70/28) | 10 | 1.67 |
ACL acute compression and lengthening, ASAMI Association for the Study of the Method of Ilizarov, AT antibiotics treatment, BG bone graft, BT bone transport, CO compression osteosynthesis, EFI external fixation index, EFT external fixation time, F flaps, IEF Ilizarov external fixator, IMN intramedullary nailing, MA mean age, MBD mean bone defects, MFU mean follow-up, MEF monolateral external fixator, PN patient number, RD radical debridement, TSF Taylor Spatial Frame.
*1 patient lost for follow-up.
**3 patients were unable to evaluate.
***2 patients lost for follow-up.
aThe study included two groups, the mean bone defects is 4 cm in one group, and 5.4 cm in another group.
__ The data were not reported in the studies.